Octave® Bioscience, Inc. Announces Chairman of the Board, CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for its Precision Care Solution
Octave® Bioscience, Inc. Receives $10 Million Grant from The Michael J. Fox Foundation to Develop and Validate Multi-Analyte Protein Biomarker Test for Parkinson’s Disease Assessments – Businesswire
Interview with Co-Founder and COO, Melinda Thomas where she discussed the path to Octave, and how her call to "respond to the need" led to tackling the most complex neurological disease.
Series sponsored by Octave. Personalized medicine is now being applied to multiple sclerosis (MS), bringing the promise of improved care to patients and their loved ones. On the latest MS Living Well podcast, sponsored by Octave, Dr. Barry Singer & special guests, Dr. Celia Oreja-Guevara and Dr. Foley, discuss insights into treatment selection.
Series sponsored by Octave. The way we measure the impact of multiple sclerosis (MS) on daily life has remained relatively unchanged for decades, but the emergence of digital health extends care beyond clinic visits. On the latest MS Living Well podcast, Dr. Barry Singer & special guests, Jennifer Graves and Tjalf Zeimssen discuss digital health and MS.
